PRASCO 534 (R-tanna chlorpheniramine tannate 9 mg / phenylephrine tannate 25 mg)
Generic Name: chlorpheniramine/phenylephrine
Pill imprint PRASCO 534 has been identified as R-tanna chlorpheniramine tannate 9 mg / phenylephrine tannate 25 mg.
R-Tanna is used in the treatment of allergic rhinitis; cold symptoms and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. R-Tanna chlorpheniramine tannate 9 mg / phenylephrine tannate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- PRASCO 534
- chlorpheniramine tannate 9 mg / phenylephrine tannate 25 mg
- 15.00 mm
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Prasco Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
calcium phosphate dihydrate dibasic
Note: Inactive ingredients may vary.
More about R-Tanna (chlorpheniramine / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 3 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.